Biohaven Ltd.
BHVN
$29.86
-$0.54-1.78%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -16.56% | 49.87% | -78.14% | -24.00% | -41.12% |
| Total Depreciation and Amortization | 23.42% | 2.05% | 35.13% | -23.65% | 23.15% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 664.31% | -102.01% | 248.03% | 35.71% | 966.18% |
| Change in Net Operating Assets | -129.32% | 188.02% | -190.99% | 393.89% | -413.45% |
| Cash from Operations | -20.86% | 15.81% | -63.49% | 10.66% | -21.17% |
| Capital Expenditure | 91.98% | 79.28% | -570.23% | 6.38% | 62.34% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -100.00% | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 5.56% | 2.31% | -378.70% | 1,089.55% | -105.76% |
| Cash from Investing | 6.13% | 4.63% | -387.77% | 969.47% | -106.68% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 270.33% | -75.86% | 14,258.47% | -99.11% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -347.43% | -16.48% | 293.93% | 145.44% | 93.23% |
| Cash from Financing | 239.47% | -74.97% | 9,281.33% | -98.60% | 718.41% |
| Foreign Exchange rate Adjustments | -- | 100.00% | -16.67% | 98.06% | -675.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 109.41% | -378.58% | 184.96% | -151.68% | 266.05% |
